Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4-step ASCOT in POI Women
NCT04475744Phase 3Completed
- Sponsor
- Fundación IVI
- Start
- Mar 2021
- Primary completion
- Oct 2023
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of granulocyte colony-stimulating factor in premature ovarian insufficiency (POI), sponsored by Fundación IVI. Started Mar 2021; status: completed.
02
Drugs
granulocyte colony-stimulating factor
03
Conditions
premature ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT04475744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04475744.